Original Development Brief – Amends the Immigration and Nationality Act to allow the admission of certain sons and daughters of citizens of the United States who are or have served in the Armed Forces abroad.
Original Development Brief – Explains the clinical and analytical information that FDA will likely use to evaluate an Infectious Disease Next Generation Sequencing Diagnostic device for premarket approval.
Original Development Brief – Assists FTA financial assistance recipients in complying with various Equal Employment Opportunity regulations and statutes, including the Genetic Information Nondiscrimination Act.
Original Development Brief – Expands restrictions surrounding human stem cell research in animals and establishes a new NIH steering committee to advise internal agency stakeholders on chimera research funding.
Original Development Brief – Rules on the patentability of identified gene sequences by biotech companies that has reconceptualized our understanding of patent application in the field of biotechnology.
Original Development Brief –Amends USAID Agency for International Development Acquisition Regulation (AIDAR) to include a new clause entitled “Nondiscrimination against End-Users of Supplies or Services,” which specifically mentions genetic information.